Myelodysplastic syndromes Clinical Trials

Delta Trials indexes 890 clinical trials for Myelodysplastic syndromes in its publicly accessible dataset. Of these, 126 enrolling participants at this time and 468 trials have reached completion. This research takes place spanning 1,568 research sites around the world. An additional 296 trials are in preparatory or other active non-recruiting stages. Since 2020, 143 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.